UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - irvin+s.y.+chen
6
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
2018-856 AN APPROACH FOR TARGETED CONDITIONING FOR T CELL TRANSPLANTS
UCLA researchers in the Departments of Microbiology, Immunology, and Molecular Genetics have identified a pre-conditioning reagent for Adoptive Cell Transfer (ACT). The identified reagent specifically ablates T-cells making room for infused cells to engraft and has negligible toxicities compared to traditional conditioning therapies that affect all...
Published: 9/5/2023
|
Inventor(s):
Irvin S.Y. Chen
,
Sanggu Kim
,
Masakazu Kamata
,
Gajendra Suryawanshi
,
Robert Donahue
Keywords(s):
Immunotherapy
,
Therapeutics & Vaccines
Category(s):
Therapeutics > Immunology And Immunotherapy
2015-671 Underground Shafts for Hydrogen Storage
SummaryResearchers at UCLA have developed an underground drilled shaft concept for storage of hydrogen or other gases.BackgroundOne challenge in creating a hydrogen economy is developing hydrogen gas storage solutions. Increased interest has helped the global hydrogen storage market grow to $2.6 billion in 2016, and it is expected to reach over $5...
Published: 7/19/2023
|
Inventor(s):
Adrienne Lavine
,
Hossein Kavehpour
,
Dante Simonetti
,
Richard Wirz
,
Chen Chen
,
Gabriela Bran
,
Gopinath Warrier
,
Hamarz Aryafar
,
Jonathon Kennedy
,
Joshua Jordan
,
Keith Lovegrove
Keywords(s):
Energy & Water
Category(s):
Energy & Environment > Energy Generation > Solar
,
Energy & Environment > Energy Storage
2018-749 A METHOD TO DISTINGUISH DIFFERENT RETROVIRAL VECTORS DURING INTEGRATION SITE ANALYSIS
UCLA researchers in the Department of Microbiology, Immunology, and Molecular Genetics have developed a novel gene therapy vector identifying method, capable of screening toxicities of combination therapies.TITLE: A Method to Distinguish Different Retroviral Vectors During Integration Site Analysis BACKGROUND: Many diseases originate from defective...
Published: 7/19/2023
|
Inventor(s):
Irvin S.Y. Chen
,
Gajendra Suryawanshi
,
Sanggu Kim
Keywords(s):
Gene Editing Systems
,
Gene Therapy
,
Life Science Research Tools
,
Plasmids / Vectors
,
Therapeutics & Vaccines
Category(s):
Life Science Research Tools
,
Life Science Research Tools > Plasmids/Vectors
,
Therapeutics
,
Therapeutics > Gene Therapy And Editing
2016-255 Method to Enrich for Cells Transduced with Chimeric Antigen Receptors for Gene Therapy (2016-051 rolled in)
Method to Enrich for Cells Transduced with Chimeric Antigen ReceptorsSUMMARYResearchers at UCLA have developed a method to expand chimeric antigen receptor-transduced T cells for use in immunotherapies.BACKGROUNDChimeric Antigen Receptors (CAR) T cells are promising therapeutics for the treatment of cancer and are also being considered for the treatment...
Published: 2/14/2024
|
Inventor(s):
Otto Yang
,
Jerome Zack
,
Scott Kitchen
,
Ayub Ali
,
Hwee Ng
,
Irvin S.Y. Chen
Keywords(s):
Oncology Immunotherapy
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Therapeutics > Oncology > Oncology Immunotherapy
2010-709 VIRAL EXPRESSION VECTOR Targeting HIV-1
SummaryUCLA researchers from the Department of Microbiology, Immunology, & Molecular Genetics have developed a viral expression vector that combines two reagents effective against HIV-1 infection.BackgroundHighly active antiretroviral therapy (HAART) has decreased the morbidity and mortality of human immune deficiency virus (HIV) in all parts of...
Published: 7/19/2023
|
Inventor(s):
Irvin S.Y. Chen
,
Dong Sung An
,
Geoff Symonds
,
Louis Breton
,
Michelle Millington
,
Maureen Boyd
Keywords(s):
Gene Editing Systems
,
Gene Therapy
,
Infectious Diseases
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Therapeutics > Infectious Diseases
,
Therapeutics > Gene Therapy And Editing
2000-128 TARGETING LENTIVIRAL VECTORS TO SPECIFIC CELLS AND TISSUES
SummaryResearchers in the UCLA Departments of Medicine and Microbiology, Immunology and Molecular Genetics have developed retroviral vectors pseudotyped with a modified Sinbus virus envelope that exhibit reduced tropism and can be used for the targeted transduction of heterologous genes into cells.BackgroundThere have been numerous attempts to develop...
Published: 7/19/2023
|
Inventor(s):
Irvin S.Y. Chen
,
Kouki Morizono
Keywords(s):
Drug Delivery
,
Gene Editing Systems
,
Gene Therapy
,
Therapeutics & Vaccines
Category(s):
Platforms > Drug Delivery
,
Therapeutics
,
Therapeutics > Gene Therapy And Editing